Turing Pharmaceuticals Martin Shkreli Hikes Drug Price 5000%

Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim and immediately increased the cost from $13.50 to $750 per pill.

Daraprim, known generically as pyrimethamine, is used mainly to treat toxoplasmosis, a parasite infection that can cause serious or even life-threatening problems for babies born to women who become infected during pregnancy, and also for people with compromised immune systems, like AIDS patients and certain cancer patients.

UPDATE: Drug C.E.O. Martin Shkreli Arrested on Fraud ChargesĀ  http://nytimes.com/2015/12/18/business/shkreli-fraud-charges.html